The FDA announced on December 3, 2014, that Hospira Inc. is recalling Fentanyl Citrate Injection due to a lack of assurance of sterility caused by improperly crimped fliptop vials. The agency classified the recall as Class II.
How to tell if you have it
- Brand: Hospira
- Product: Fentanyl Citrate Injection, USP, 2500 mcg Fentanyl/50 mL, 50 mL Single-dose Flip top Vial (C-II), Rx only
- NDC: 0409-9094-61
- Lot code: 41-099-DK
- Expiration date: 01MAY2016
- Quantity: 62,650 vials
The hazard
The recall addresses a lack of assurance of sterility resulting from improperly crimped fliptop vials. The FDA classified the recall as Class II.
Context
GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls of similar products include Huons Co Lidocaine HCl Injection Recall (April 2, 2026) and Wells Pharma Fentanyl Citrate Injectable Solution Recall (April 1, 2026).